Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACENasim Mavaddat, Susan Peock, Debra Frost et al.|JNCI Journal of the National Cancer Institute|2013Cited by 946
Germline <i>BRCA</i> Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate CancerElena Castro, Rosalind A. Eeles, Chee Goh et al.|Journal of Clinical Oncology|2013Cited by 833
Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate CancerElena Castro, Rosalind A. Eeles, Chee Goh et al.|European Urology|2014Cited by 374
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriersAntonis C. Antoniou, Rosalind A. Eeles, Karoline Kuchenbaecker et al.|Breast Cancer Research|2012Cited by 96
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian CancersHuong Meeks, Pascal Guénel, Anja Rudolph et al.|JNCI Journal of the National Cancer Institute|2015Cited by 92